Tata Consultancy Services has launched TCS ADD™ AgentHub, a role-based AI platform designed to deploy agentic AI across pharmaceutical drug development, clinical trials, and pharmacovigilance operations.
The platform, announced August 17, 2026, gives pharma companies a structured framework to run AI agents with defined roles, oversight, and built-in auditability in highly regulated environments. Growing data volumes, fragmented systems, and stricter regulatory expectations have made it difficult for drug developers to apply AI across the R&D value chain; TCS designed AgentHub to address the trust, governance, and scalability problems that typically emerge in those conditions.
Measured efficiency gains
TCS says the platform's AI agents deliver specific operational improvements in drug development and drug safety: up to 40% efficiency gains in clinical data management, up to 30% reduction in clinical study build effort through metadata-driven automation, and up to 30% cost savings in end-to-end safety case processing. AI-powered safety agents can cut quality control effort by as much as 50%.
The platform runs on the existing TCS Agentic AI architecture and supports a "Human + AI Operating Model" where agents are embedded into enterprise workflows but humans retain responsibility for governance and decision-making.
What the agents handle
AgentHub covers workflows across clinical development and pharmacovigilance, including intake and data entry, coding, review, literature analysis, protocol digitization, study design, clinical data review, SDTM transformation, and medical monitoring assistance.
The company positions the platform as a catalog of AI agents that can be deployed progressively with minimal integration, based on each organization's needs and infrastructure. This approach standardizes deployment across processes so scientific teams can focus on higher-value work rather than routine data tasks. For professionals looking to build skills in this area, AI Agents & Automation Courses can provide foundational knowledge for working with this technology class, while IT professionals can explore AI for IT & Development training to apply AI in their own technical workflows.
Regulatory confidence
Debashis Ghosh, President, Lifesciences and Healthcare, TCS, said in a statement: "TCS ADD™ AgentHub, is a role-based, enterprise-ready, and trusted AI platform that will enable our customers to accelerate drug development using agentic AI at scale. It enables a shift from reactive to proactive, scalable, and audit-ready operations amidst an ever-changing regulatory environment."
TCS's strategy, according to the company, is to move toward "autonomous enterprise functions where AI agentic workforce operates alongside humans driving innovation in drug development and improving patient safety."
Why this matters for IT and development professionals
For IT teams working in pharma or similar regulated sectors, the platform offers a reference point for an AI architecture designed for audit readiness rather than just feature deployment. The focus on trackable roles, human oversight, and progressive integration provides a clear model for how agentic AI can operate under compliance constraints - particularly useful for platform engineers and architects considering how to ground agent-based systems in verifiable workflows that can handle controlled, high-stakes data.
Your membership also unlocks:
